Deloitte’s 2026 Healthcare Outlook: Key Findings on Confidence, Digital Health, AI and Partnerships

Deloitte’s 2026 Healthcare Outlook shows that while more than two-thirds of U.S. healthcare leaders expect to outperform competitors, rising policy uncertainty is pushing greater focus on digital care, AI and partnerships. The post Deloitte’s 2026 Healthcare Outlook: Key Findings on Confidence, Digital Health, AI and Partnerships appeared first on MedCity News.

Read More

DEI Is Now a Four Letter Word

By KIM BELLARD I’d love to be writing about something fun. Something that makes us think about things in a new way, or something exciting that will take us into the future. There are lots of such things happening, but there’s too many Orwellian actions happening that I can’t be silent about. Diversity, we’re told,…

Read More

Montana Lawmakers Approve $124M To Revamp Behavioral Health System

HELENA, Mont. — Montana’s frayed behavioral health care system, still recovering from the effects of past budget cuts, will get a shot in the arm after state lawmakers approved sweeping changes to upgrade and expand facilities, increase community services, and revise commitment procedures. Lawmakers backed the bulk of Republican Gov. Greg Gianforte’s multimillion-dollar vision to…

Read More

Comorbidities Are Driving Up Healthcare Costs — Here’s How More Specialized Care Management Can Bring Them Under Control

To bend the cost curve, we need a smarter, more integrated approach to care management — one capable of addressing rising upstream cost drivers, while still delivering high-quality, patient-centered outcomes.  The post Comorbidities Are Driving Up Healthcare Costs — Here’s How More Specialized Care Management Can Bring Them Under Control appeared first on MedCity News.

Read More

Watching Where and How You’re Walking

By MIKE MAGEE In a speech to the American Philosophical Society in January, 1946, J. Robert Oppenheimer said, “We have made a thing …that has altered abruptly and profoundly the nature of the world…We have raised again the question of whether science is good for man, of whether it is good to learn about the…

Read More

Medicaid Coverage of and Spending on GLP-1s

This brief examines the implications of rising prescriptions for costly GLP-1 drugs for state Medicaid programs as more states consider covering the drugs for weight loss. It examines recent trends in Medicaid prescriptions and gross spending on GLP-1s, and explores the potential implications of expanding coverage obesity drugs for Medicaid programs.

Read More